Welcome to Abhijit Kunte and Kanak Sharma who have joined Bryan Garnier’s Technology team
Abhijit Kunte
Investment Banking
Abhijit joined Bryan, Garnier & Co in 2021.
Previously, Abhijit worked as an AVP at Technology Holdings and as a Manager in corporate development at Tech Mahindra Limited.
Abhijit has completed various transactions including the sale of Nielsen+Partners to Larsen and Toubro Infotech and acquisition of Pininfarina S.p.A. by Tech Mahindra.
Abhijit holds an MBA from the Bond University in Australia and is a CPA (USA).
Kanak Sharma
Investment Banking
Kanak joined Bryan, Garnier & Co in October 2021 as Associate in the Technology team.
She has gained experience as an M&A Banker at IEG-Investment Banking Group and as a consumer tech investor at Nucom (Joint company of General Atlantic & ProSiebenSat.1). During her career, she has developed a knowledge of various sectors including Fintech, Clean Tech, B2B logistics, Proptech/ Real estate tech & E-commerce.
She holds a bachelor’s degree in economics & Statistics.
Behind the scene : the stake of private growth financing in the client lifecycle approach of Bryan, Garnier & Co
Behind the scene : the stake of private growth financing in the client lifecycle approach of Bryan, Garnier & Co
As most of you know, supporting European growth companies by raising private growth capital has been a pillar of Bryan, Garnier & Co strategy since 1996, when I left the venture capital industry to co-found the first European growth investment bank.
Deep roots in the private capital markets
Inspired by the critical role played in the US venture ecosystem in the 80s and 90s by the four Horsemen (the HARMs, namely Hambrecht & Quist, Alex Brown & Sons, Robertson, Stephens & Co, and Montgomery Securities), and a strong belief that European innovation and growth communities needed highly specialized investment banks to sponsor the most promising disruptive growth companies throughout their lifecyle, providing them with strategic insights, access to private capital, taking them public, advising them on acquisitions or selling them at the best time, we started our journey by pioneering the later stage growth financing market in Europe.
More than two decades of commitment to private growth companies
Since 1996, Bryan, Garnier & Co has led close to 200 later stage venture and growth capital rounds, raising close to € 5 billion of financing for European companies. Since 1996, we have kept the same mindset, a relentless commitment to back entrepreneurs and support their companies for the long run, in good and tough times, with, as only tie, the necessity to keep their trust and confidence. Whether they thrive or face adversity, we keep on investing our time and efforts, providing our insights and expertise to help grow the companies we sponsor, as their long term success is the fuel of our own expansion. Amongst the companies we have backed, a number have become unicorns, and some are today leading players of their markets with dozens of billions of market caps.
During this journey we have accumulated an unparalleled knowledge and experience, in terms of transaction scope – from series B, C and beyond, to pre-IPO, crossover rounds, direct listings, cornerstoned IPOs or PIPEs, across the range of equity and equity linked securities.
We have raised capital throughout geographies – EMEA, Americas and Asia- and asset classes – conventional investors such as VCs and growth capital investors, as well as non-conventional investors such as corporates, hedge funds, pension or sovereign funds and family offices.
Over the past few weeks, we announced the closing of a €100m series B for Agronutris, a leading insect-based alternative-protein player which benefited from the first private investment of European ESG asset manager Mirova, we closed a €65m PIPE for Claranova with Susquehanna’ Heights Capital, or conducted the $40m privately placed listing on Euronext Oslo of leading LEO satellite constellation Astrocast with Adit Ventures and Palantir amongst others.
Expansion of the asset class drives higher stakes and higher complexity
Over the recent years, as venture and growth capital was outperforming private equity buy-outs, massive amount of capital flowed to the market, providing the opportunity for private companies to secure more capital than ever, enabling them to pursue their development to a much higher level of ambition than before : during the past 12 months, average series C rounds have tripled in value reaching on average $75m , while series D and beyond are now above $155m.
With the increase in size of the rounds comes the increase of sophistication, in the number and the nature of investors syndicated in the rounds, in the structures of the financings, in the transaction processes and the scope of due diligences, in the terms of corporate governance.
The blurring of the frontier between private and public capital markets, from the amount of capital available, to the increased diversity in the profiles of investors (increasing number of public equity asset managers, corporates, hedge funds and crossover investors venturing in the private asset class), has also increased the scope of financing alternatives.
Private and public equity capital markets are solutions to the same issue : financing growth
The remarkable performance of the European and US equity capital markets for growth companies over the past 15 years nourished by the underlying secular transformation trends of the economy (digitalization, health and care, energy transition, sustainability), have increased the appetite for risk and performance of the public equity investors, demonstrated by the massive expansion in number and value of biotech, new energy, fintech, newspace, alternative proteins, cannabis… companies over the past 5 years, enabling highly disruptive issuers to access to significant sources of liquidity at a quite early stage of their development.
Standing at the crossroads of growth financing solutions
Entrepreneurs and companies are today living in an environment of high expectations with a lot at stake : The experience accumulated as one of the most active underwriter of public offerings (IPOs and follow-ons) for tech and healthcare European growth companies in all key European stock markets and on the US Nasdaq, combined with our longstanding involvement in the venture capital ecosystem gives us an unparalleled ability to support European growth companies at all stage of their development, providing them unbiased guidance to best navigate through these fast evolving private and public equity financing environments.
Industry in the Digital Age
Tuesday 30 November 2021 | 09h – 18h CET
Industry in the Digital Age
Industry 4.0 is set to take a giant leap in the next decade as Western leaders contemplate the relocation of manufacturing capacity on national soil requiring intelligent, hyperconnected, and flexible industrial sites, a new paradigm enabled by the rise of new technologies.
Our conference will gather executives from companies enabling this paradigm shift, revealing insights into the future of the industrial world.
Registration
Registration is closed
Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Alexandre has been appointed Senior Associate in the Business & Tech-enabled Services Team.
Alexandre Deranque
Investment Banking
Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Alexandre has been appointed Senior Associate in the Business & Tech-enabled Services Team.
Alexandre joined Bryan, Garnier & Co in November 2021 as Senior Associate in the Business & Tech-enabled Services team.
He gained experience in corporate finance during his internships spent at MBA Capital and Rothschild & Co (Transaction R) and then passed 6 years at PwC in the Audit and Transaction departments. During his career, he has developed a knowledge of various sectors including textile, aerospace, agrifood, automotive and waste treatment.
Alexandre holds a double degree master in Management and Msc in Finance from EDHEC Business School and also holds a chartered accountant diploma (French CPA).
Fast Growth Icons
28 October 2021 | Berlin
Fast Growth Icons
Once again, Bryan, Garnier & Co is supporting this year’s Fast Growth Icons in Berlin.
Fast Growth Icons is focused on practical advice for tech growth businesses, coupled with networking, bringing together around 100 founders and CEOs of highly successful and fast-growing companies.
Event highlights
- Invitation-only network for founders and CEOs of the most successful tech businesses
- Focuses on the key areas that growth businesses need to get right to maintain and manage rapid growth and build the €100m+ revenue businesses of the future
- Closed-doors environment where founders can openly share their ambitions and challenges and get valuable insights from speakers and participants
- Attended by some of the region’s most interesting founders (the typical attendee is the founder of a business with €10m-€100m turnover and/or 75-500 staff, growing at over 50% p.a.).
Registration
Registration is closed
Halla Koppel joins Bryan, Garnier & Co as Vice President in Investment Banking
Halla Koppel
Investment Banking
Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Halla has been appointed as Vice President in Investment Banking.
Halla joined Bryan, Garnier & Co in September as Vice President in investment banking with a specialisation in ESG products. Previously Halla worked at Goldman Sachs, as part of their cross-asset coverage for Nordic institutional clients. Halla has an MBA from the University of Oxford, holds a Certificate in Sustainable Finance from Cambridge University and a CFA level 4 in ESG investing. Halla also has a long career in media and entertainment behind her, has climbed four of the World´s highest Seven Summits and is a keen motorcyclist.
Caroline Brun joins Bryan, Garnier & Co as Vice President in the Business & Tech-enabled Services Team
Caroline Brun
Investment Banking
Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Caroline has been appointed as Vice President in the Business & Tech-enabled Services Team.
Caroline joined Bryan, Garnier & Co in September 2021 as Vice President in the Business & Tech-enabled Services team. She has 10 years’ corporate finance experience gained at Neuflize OBC Corporate Finance team and Deloitte Transaction Services. During her career, Caroline has been responsible for numerous deals with companies and investment funds, including La Grosse Equipe/Satisfaction, MagicOnline/Banque Palatine & NeuflizeOBC, Solware/Andera Acto and Be Relax/Activa Capital. She is a graduate of NEOMA Business School (Sup de Co Reims).
Bryan, Garnier & Co Monthly IPO Fireside Chat
Thursday 15 July 2021 | 10h00 CET - 10h45 CET
Bryan, Garnier & Co Monthly IPO Fireside Chat
WITH:
Greg Revenu | Co-founder & Managing Partner
Pierre Kiecolt-Wahl | Partner and Head of Equity Capital Markets
THIS MONTH:
TBC
The Bryan, Garnier & Co monthly IPO fireside chat is part of a series of conversations set up to discuss the capital markets environment, recent key transactions and trends (direct listings, SPACs…), institutions investors behaviours (cornerstone, crossovers…), valuation dynamics (Europe vs US). These conversations are a unique opportunity for private equity professionals to get a comprehensive and updated view on the market dynamics in an interactive format.
Registration
Registration is closed
Jérôme Guyot joins Bryan, Garnier & Co as Managing Director – Equity Capital Markets
PARIS, 1 July 2021 – Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Jérôme Guyot has been appointed as Managing Director, ECM at the firm.
Based in Paris, Jérôme will help further drive Bryan, Garnier & Co’s ECM franchise and help the firm achieve its ambition to become the leader in ECM for growth companies.
Jérôme, 45, has a 15-year career in the investment banking industry. Before joining Bryan, Garnier & Co, he worked at a variety of companies including Gilbert Dupont – Groupe Société Générale, where he was Head of ECM and then Co-Head of Corporate Finance, and Groupe Crédit du Nord as Director, ECM.
Over his career, Jérôme has executed more than 70 ECM transactions across a range of industries, including tech, healthcare, and consumer, which are core sectors for Bryan, Garnier & Co. He has completed advisory and capital markets transactions for clients such as Advicenne, Alchimie, Ateme, Ekinops, Fermentalg, Gensight Biologics, Inventiva, Median Technologies, Nacon, Nanobiotix and Sidetrade.
Christophe Alleman, Co-Head Equity Capital Markets states: “We are delighted to welcome Jérôme to Bryan, Garnier & Co as Managing Director in our Equity Capital Markets franchise. Jérôme brings a long and established track record of ECM success in the French small and mid-cap market, which represents the largest pool of publicly listed small and mid-cap companies in continental Europe.”
Jérôme Guyot comments: “I am more than happy to join Bryan, Garnier & Co’s highly committed team to help expand our ECM franchise. I have been very impressed by the ability of the firm to bring in strategic cornerstone investors in the context of IPOs and follow-on offerings. This is a perfect illustration of the firm’s value proposition to support growth companies and disruptive players at all stages of their development”.
With more than 60 private and public capital-raising and M&A transactions closed in 2020, Bryan, Garnier & Co benefits from longstanding leadership in the healthcare, technology, business services and environmental sectors in Europe. Over the past 36 months, Bryan, Garnier & Co has led more than 40 ECM transactions across nine countries, raising over EUR 2.5bn. Recent successes include the IPOs and/or follow-ons for HDF Energy (Euronext Paris), Mister SPEX (Deutsche Boerse), Carbios (Euronext Paris), Azelio (NASDAQ Stockholm), McPhy Energy (Euronext Paris), Linas Matkase (NASDAQ Stockholm), Heidelberg Pharma (Deutsche Börse), Swedish Stirling (NASDAQ Stockholm), Basilea (SIX) GenSight (Euronext Paris), and Valneva (NASDAQ / Euronext Paris).
Additional recent transactions include the acquisition of DL Software by TA Associates, the sale of smartTrade to leading software private equity investor Hg Capital, the take-private of ITSM player Easyvista by Eurazeo, capital for circular economy player asgoodasnew, the sale of Specim to Konica Minolta and the sale of BlueBee to Illumina. Over the years, Bryan, Garnier & Co has distinguished itself by backing some of the most disruptive companies in the domain of alternative proteins (Prolupin), green hydrogen (McPhy Energy), cannabis (Canopy Growth), 3D printing (Materialise), blockchain and cryptocurrencies (Bitfury Group), and mRNA biotech (Moderna and BioNTech).
Sanjin Goglia, former cybersecurity lead at Atos Group M&A joins Bryan, Garnier & Co as Managing Director
PARIS, 1 June 2021 – Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that Sanjin Goglia has been appointed as Managing Director at the firm.
Based in Paris, Sanjin will take up this new position to help develop Bryan, Garnier & Co’s business and strategy in the rapidly growing cybersecurity and compute infrastructure markets in Europe.
Sanjin, 40, has a distinguished career in digital security gained from working at large corporates such as Siemens and Deloitte as well as small start-ups focused on data analytics. He joined Atos in 2011, where he held multiple roles including; dealmaker for large, cross-border deals, global business leadership roles in the big data and cybersecurity divisions, and finally in Group M&A. In this position, he was responsible for advancing the cybersecurity acquisition strategy across Europe and US as one of the key focus areas of the Group.
During Sanjin’s career he has worked with clients on security deals and programmes around the world as well as on multiple recent cybersecurity acquisitions by Atos.
Olivier Beaudouin, Partner within the Technology team states: “We are delighted to welcome Sanjin to Bryan, Garnier & Co. He brings both a wealth of business experience and an extensive network in some of the key technology growth markets in Europe, which will help us expand our business footprint and support our strategic ambitions”.
Sanjin Goglia comments: “I have been impressed by Bryan, Garnier & Co’s highly committed team and their deep focus on building distinguished industry expertise. With strong recognition in the technology markets and a successful track record in supporting growth companies and their shareholders at all stages of their development, the firm is ideally positioned to become a leading cybersecurity and compute infrastructure advisor in Europe”.
With more than 60 private and public capital-raising and M&A transactions closed in 2020, Bryan, Garnier & Co benefits from its longstanding leadership in the healthcare, technology and environmental sectors in Europe. Recent transactions in the tech space include the acquisition of DL Software by TA Associates, the sale of Easyvista to Eurazeo, the sale of Specim to Konica Minolta, the acquisition of Diapason by Apax, the sale of Ginolis to Cellink, the investment of Hg Capital into Smarttrade.
Over the years, Bryan, Garnier & Co has been active in the cybersecurity and infrastructure fields with deals including a EUR 20m series C financing for cyber threat intelligence company EclecticIQ, the acquisition of IT infrastructure and cybersecurity company Metsys by European Digital Group, the acquisition of Kompetera by Advania, a USD 80m series D financing for blockchain unicorn Bitfury and the sale of the cybersecurity specialist Lexsi to Orange Cyber Defense.